| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 66 |
| 1 | ALBUTEROL SULFATE | 27 |
| 2 | METHOTREXATE SODIUM | 27 |
| 3 | METHOTREXATE | 23 |
| 4 | CANDESARTAN | 20 |
| 5 | FUROSEMIDE | 20 |
| 6 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 18 |
| 7 | MEPOLIZUMAB | 18 |
| 8 | CALCIUM | 17 |
| 9 | ACETAMINOPHEN | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUGAMMADEX SODIUM | 4 | 0.0030 |
| 1 | THEOPHYLLINE ANHYDROUS | 8 | 0.0006 |
| 2 | CANDESARTAN | 20 | 0.0006 |
| 3 | ROCURONIUM BROMIDE | 5 | 0.0004 |
| 4 | MOMETASONE FUROATE | 16 | 0.0004 |
| 5 | LACTULOSE | 14 | 0.0004 |
| 6 | DEXLANSOPRAZOLE | 15 | 0.0004 |
| 7 | MEPOLIZUMAB | 18 | 0.0004 |
| 8 | ERGOCALCIFEROL | 9 | 0.0003 |
| 9 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 18 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 24 |
| 1 | Proton Pump Inhibitor [EPC] | 24 |
| 2 | Corticosteroid [EPC] | 21 |
| 3 | Loop Diuretic [EPC] | 21 |
| 4 | Atypical Antipsychotic [EPC] | 18 |
| 5 | Interleukin-5 Antagonist [EPC] | 18 |
| 6 | Calcium [EPC] | 17 |
| 7 | Kinase Inhibitor [EPC] | 17 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 9 | Expectorant [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 18 | 0.0262 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 5 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |
| 6 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 7 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 9 | Nonergot Dopamine Agonist [EPC] | 3 | 0.0002 |